ORIGINAL RESEARCH article
Front. Public Health
Sec. Health Economics
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1631872
This article is part of the Research TopicInnovative Value-Based Medicine: Lessons from China's Healthcare EvolutionView all 13 articles
Unpacking the Cost Implications of Diagnosis-Related Groups Reform for Lumbar Disc Herniation Patients in Chinese Medicine: A Closer Look at Evidence from China
Provisionally accepted- 1Beijing University of Chinese Medicine, Beijing, China
- 2Gansu University of Chinese Medicine, Lanzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objectives: Lumbar disc herniation (LDH) presents a significant economic burden globally, worsening in China due to an aging population. Traditional Chinese Medicine (TCM) offers effective treatment options for LDH, making its integration with Diagnosis-Related Groups (DRG) payment reform crucial for reducing medical costs and enhancing healthcare quality. Methods: We analyzed data from hospitalized patients at Qingyang City Hospital of Chinese Medicine, Gansu Province, from 2017 to 2022. Univariate analysis was conducted to examine changes in patient demographics before and after the DRG reform. A single group interrupted-time series analysis (ITSA) model was used to compare key indicators of medical costs and length of stay pre-and post-reform. Results: A total of 2,857 LDH patients were included in the study. No significant differences were found in nationality, marital status, use of Chinese medicine diagnostic and therapeutic equipment, use of Chinese medicine diagnostic and treatment techniques or diagnosis and treatment based on Chinese medicine evidence (P>0.05). This is a provisional file, not the final typeset article However, significant differences were noted in sex, age, visit times, admission pathways, admission disease status, complications and comorbidities, and surgeries and operations (P<0.05). Healthcare-related costs and length of stay are associated with sex, age, visit times, and other factors, showing a positive correlation among different costs and length of stay (P<0.05). Post-reform, average monthly hospitalization cost decreased by CNY 36.78 ( 1 + 3 =−36.78, P<0.05), Chinese medicine cost fell by CNY 8.87 ( 1 + 3 =−8.87, P<0.05), and Western medicine cost dropped by CNY 31.68 (1 + 3 =−31.68, P<0.05). While the rising trend in diagnosis cost was curtailed, both medical services cost and TCM treatment cost increased, with the length of stay remaining stable. Conclusion: The DRG reform is associated with lower hospitalization cost and reduced costs for both Chinese medicine and Western medicine. However, its impact on overall medical services cost, diagnosis cost, TCM treatment cost, and length of stay is limited. Future DRG reform should leverage the distinctive advantages of TCM, enhance the payment system, improve treatment outcomes, and further reduce healthcare costs while shortening hospitalization times.
Keywords: LDH1, DRG2, TCM3, hospitalization cost4, Chinese medicine hospitals5
Received: 27 May 2025; Accepted: 04 Sep 2025.
Copyright: © 2025 Chen, Wang, Yu, Xia, Zhang, Wang, Yuan, Jia, Sun, Wu, Wang, Cong, Kong, Haojia, Yang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zhi-Wei Wang, Beijing University of Chinese Medicine, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.